Flyak, Andrew I.
Kuzmina, Natalia
Murin, Charles D.
Bryan, Christopher
Davidson, Edgar
Gilchuk, Pavlo
Gulka, Christopher P.
Ilinykh, Philipp A.
Shen, Xiaoli
Huang, Kai
Ramanathan, Palaniappan
Turner, Hannah
Fusco, Marnie L.
Lampley, Rebecca
Kose, Nurgun
King, Hannah
Sapparapu, Gopal
Doranz, Benjamin J.
Ksiazek, Thomas G.
Wright, David W.
Saphire, Erica Ollmann
Ward, Andrew B.
Bukreyev, Alexander http://orcid.org/0000-0002-0342-4824
Crowe, James E. Jr http://orcid.org/0000-0002-0049-1079
Article History
Received: 11 May 2017
Accepted: 6 April 2018
First Online: 7 May 2018
Competing interests
: C.B., E.D. and B.J.D. are employees of Integral Molecular. B.J.D. is a shareholder of Integral Molecular. J.E.C. is a consultant for Sanofi, and is on the Scientific Advisory Boards of PaxVax, CompuVax, GigaGen and Meissa Vaccines, is a recipient of previous unrelated research grants from Moderna and Sanofi and is founder of IDBiologics. A.I.F., P.A.I., A.B. and J.E.C. are co-inventors on a patent applied for that includes the BDBV223, BDBV317 and BDBV340 antibodies.